The Marshall Project reports that despite initial stock surges for private prison companies under Trump, their values fell as immigration enforcement didn’t meet expectations.
It is considered one of the most famous UFO encounters in history. A US sergeant said a UFO beamed a binary coded message ...
Ten stocks boasted whopping gains on Thursday, outperforming Wall Street’s main indices, as investors took heart from a flurry of analyst ratings and corporate developments. Of the 10 firms, five ...
Caruso ended with seven points (2-4 FG, 0-1 3Pt, 3-3 FT), three rebounds, two assists, two blocks and one steal across 24 minutes during Friday's 117-116 win over Memphis. Caruso moved around well in ...
Stock markets pulled back Thursday as an early-year rally ran out of steam, with investors locking in profits ahead of the release of key US jobs data this week. The geopolitical outlook remained a ...
Warby Parker rallied for a third day on Tuesday, jumping 11.57 percent to finish at $25.94 apiece as investors took heart from an investment firm’s price target upgrade for its stock. In an updated ...
[Stay on top of transportation news: Get TTNews in your inbox.] A gauge of U.S. transportation stocks is on track to set a record, capping a steady recovery after a long slump fueled by the global ...
A gauge of US transportation stocks is on track to set a record, capping a steady recovery after a long slump fueled by the global trade turmoil last year. The Dow Jones Transportation Average rose as ...
Barnes totaled 20 points (8-14 FG, 4-5 FT), seven rebounds, four assists, two blocks and three steals across 32 minutes during Saturday's 134-117 victory over the Hawks. Barnes did a little bit of ...
Last year in crypto will be remembered for many things, but one notable trend — particularly late in the year — was the selloffs that occurred nearly every day during U.S. trading hours. It's not much ...
The Family of Blood is terrifying because of their cold, parasitic nature. These creatures aren’t seeking galactic conquest or to destroy the timeline; they just want to live forever by consuming a ...
Outlook Therapeutics, Inc. (NASDAQ: OTLK) stock sank to a new 52-week low on Friday after the U.S. Food and Drug Administration (FDA) again rejected its Lytenava filing for wet AMD, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results